Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

(Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new analyses from the HELIOS-B Phase 3 study of vutrisiran in patients with the cardiomyopathy of wild-type or hereditary ...

Add Yahoo as a preferred source to see more of our stories on Google. TUPELO — The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to ...

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

From next-generation medications to groundbreaking gene therapies and nonsurgical procedures, explore the pipeline of ...

Heart disease continues to rank as the leading cause of death in the Black community, claiming thousands of lives annually. While lifestyle modifications remain foundational to heart health, modern ...

The device and drug combination was trialled at 20 hospitals around the UK. Sign up for the top news stories every day to ...

Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...

For millions of people with heart failure, the latest treatment options — including advanced surgical procedures and innovative devices to assist a failing heart — can be game-changing, especially ...

Cholesterol meds can help lower heart risk, but they’re not for everyone. Here’s how to know if you should take a statin based on your own cardiovascular risks.

Metoprolol, acebutolol, and propranolol are heart medications linked to weight gain. Other heart medications may cause weight gain, but some might cause weight loss or be weight neutral. Many ...